Shuttle vector to generate rAd with GFAP promoter
Clone info. | Shuttle vector to generate rAd. Inserted sequence is regulated under the control of GFAP promoter. |
---|---|
Comment | GFAP-SwaI-SV40pA fragment (1.2k) was cloned on SwaI site of pAdex1cw. Produce adenovirus by COS-TPC method. |
Vector backbone | pAxcw (Cosmid, use packaging extracts for transforming E. coli host) |
Selectable markers | Amp^r |
Gene/insert name | Mouse GFAP |
Depositor|Developer | Hashimoto, Mitsuhiro | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Approval form by depositor [Word ![]() Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | This material is provided with written consent of Depositor. Manuscripts for the publication shall be made through the discussion between Developer/Depositor and Recipient investigator. |
Remarks | ((Additional form)) Approval Form(FormD) Remember that you will be working with samples containing infectious virus. Please obtain written approval of the depositor. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 寄託者による提供承諾書 [Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 寄託者に許可をとること。使用にあたっては、常に連絡をとり、発表等に関しても事前に合意を要する。 |
備考 | 【追加提供依頼書】承諾書(FormD) このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 寄託者の書面による提供承諾が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB06015 | pAdex GFAP-SwaI-SV40pA | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pAdex GFAP-SwaI-SV40pA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06015). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB13141_A5Br.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pAdex_F Sequence file: RDB13141_A5Bra.seq ![]() |
---|
>06015_13141_A5Br_pAdex_F_E10_13.ab1 1 CAGTTACGCA CACTCGCAGG GTCTGCACCT GGTGCGGGTC TCATCGTACC TCAGCACCTT 61 CCAGATCCAT CGTCGCGAGT CGACAATCGA TTTGGTGGCG GCCGCTCTAG AACTAGTGGA 121 TCCCCCGGGC TGCAGGAATT CGATATCAAG CTTGTAATTC GGTTTCCTCG GCCCTCTCTT 181 GACCCATTTA CCAGAAAGGG GGTTCCTTGA TCAATGGCGA AGCCAGGCTG GTGTTCCCAA 241 GAAAGCCTTG ACTCTGGGTA CAGTGACCTC AGTGGGGTGA GAGGAGTTCT CCCCTTAGCT 301 GGGCTGGGGC CCAGCTCCAC CCCCTCAGGC TATTCAATGG GGGTGCTTCC AGGAAGTCAG 361 GGGCAGATTT AGTCCAACCC GTTCCTCCAT AAAGGCCCTG ACATCCCAGG AGCCAGCAGA 421 GGCAGGGCAA GCTTATCGGA TCCCCCATTT AAATCGGGCT GCAGGAATTC GATATCAAGC 481 TTATCGGATC TTTGTGAAGG AACCTTACTT CTGTGGTGTG ACATAATTGG ACAAACTACC 541 TACAGAGATT TAAAGCTCTA AGGTAAATAT AAAATTTTTA AGTGTATAAT GTGTTAAACT 601 ACTGATTCTA ATTGTTTGTG TATTTTAGAT TCCAACCTAT GGAACTGATG AATGGGAGCA 661 GTGGTGGAAT GCCTTTAATG AGGAAAACCT GTTTTGCTCA GAAGAAATGC CATCTAGTGA 721 TGATGAGGCT ACTGCTGACT CTCAACATTC TACTCCTCCA AAAAAGAAGA GAAAGGTAGA 781 AGACCCCAAG GACTTTCCTT CAGAATTGCT AAGTTTTTTG AGTCATGCTG TGTTTAGTAA 841 TAGAACTCTT GCTTGCTTTG CTATTTACAC CACAAAGGAA AAAGCTGCAC TGCTATACAA 901 GAAAATTATG GGAAAAATAT TCTGTAACCT TTATAAGTAG CATAACAGTT ATATCATAAC 961 ATACTGTTTT TTCTACTCAC ACAGCATAGA GTGTCTGCTA TATACTATGC TCAAAATTGT 1021 GTACTTTAGC TTTTACTTGT AAAGGGGTTA TAGGAATAAT TGATGGAATA TGCCCTTGGA 1081 CTGAGCAGTC TAATCAAGCC AGTACCACAC TTGATATAAG GGAGTATGAT // |
Primer: pJB8-Forward Sequence file: RDB13141_A5Brb.seq ![]() |
>06015_13141_A5Br_pJB8-Forward_F10_16.ab1 1 GATGCATATG ATATGAGGGG GTGGAGTTTG TGACGTGGCG CGGGGCGTGG GAACGGGGCG 61 GGTGACGTAG TAGTGTGGCG GAAGTGTGAT GTTGCAAGTG TGGCGGAACA CATGTAAGCG 121 ACGGATGTGG CAAAAGTGAC GTTTTTGGTG TGCGCCGGTG TACACAGGAA GTGACAATTT 181 TCGCGCGGTT TTAGGCGGAT GTTGTAGTAA ATTTGGGCGT AACCGAGTAA GATTTGGCCA 241 TTTTCGCGGG AAAACTGAAT AAGAGGAAGT GAAATCTGAA TAATTTTGTG TTACTCATAG 301 CGCGTAATAT TTGTCTAGGG CCGCGGGGAC TTTGACCGTT TACGTGGAGA CTCGCCCAGG 361 TGTTTTTCTC AGGTGTTTTC CGCGTTCCGG GTCAAAGTTG GCGTTTTATT ATTATAGTCA 421 GCATCGATTT TCGAGGTCGA CGGTATCGGA TCCAGACATG ATAAGATACA TTGATGAGTT 481 TGGACAAACC ACAACTAGAA TGCAGTGAAA AAAATGCTTT ATTTGTGAAA TTTGTGATGC 541 TATTGCTTTA TTTGTAACCA TTATAAGCTG CAATAAACAA GTTAACAACA ACAATTGCAT 601 TCATTTTATG TTTCAGGTTC AGGGGGAGGT GTGGGAGGTT TTTTAAAGCA AGTAAAACCT 661 CTACAAATGT GGTATGGCTG ATTATGATCT CTAGTCAAGG CACTATACAT CAAATATTCC 721 TTATTAACCC CTTTACAAAT TAAAAAGCTA AAGGTACACA ATTTTTGAGC ATAGTTATTA 781 ATAGCAGACA CTCTATGCCT GTGTGGAGTA AGAAAAAACA GTATGTTATG ATTATAACTG 841 TTATGCCTAC TTATAAAGGT TACAGAATAT TTTTCCATAA TTTTCTTGTA TAGCAGTGCA 901 GCTTTTTCCT TTGTGGTGTA AATAGCAAGC AAGCAGAGTT CTATTACTAA ACACAGCATG 961 ACTCAAAAAC TAGCAATTCT GATGAAAGTC CTTGGGGTCT CCTACTTTCT CTTCTTTTTT 1021 GGAGGAGGTA GATGGTGAGA GTCAGCAGTA GCCTCCATCA CTCACTCAGG ATGGGCAGTT 1081 CTTCTGGAGC AGAACCGGAT TGTCCTCGTA GGCGAGTTCA TCACATGCTC TCTCCAGTCA 1141 ATTCAGATTG TCGCTTACGA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content